Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interview of the week

Interview: Nadine Hachach-Haram, Proximie 

Proximie is a UK-headquartered healthtech company that has built a platform aimed at improving the way surgery is done and the way operating rooms (ORs) function. In the first few years of the company’s existence, it was essentially a telehealth platform for surgeons, helping them collaborate, guide and educate one another across the world via a video connection. But since HBI last interviewed Proximie's CEO and founder Nadine Hachach-Haram in 2023, it’s been transformed into a super-high-tech platform that uses ambient data capture and AI to optimise OR workflows and improve surgery outcomes.

Kate Newhouse (Kooth) on the need for early-intervention mental health services for young people

Kooth is a UK-based digital mental health company that provides free-at-the-point-of-use (publicly reimbursed) support to teenagers and young people in the UK and the US. In a recent conversation with HBI, Kate Newhouse, CEO, explained the company’s ethos and why there is such a need for the kind of early-intervention mental health services it provides.

2026 will see modest growth and selective mega deals — Interview with Matthew Edwards, Osborne Clarke

Healthcare and life sciences deal activity is expected to pick up in 2026, following trends seen in 2025 when the market remained steady despite regulatory challenges, according to a recent report from global law firm Osborne Clarke. HBI spoke to Matthew Edwards, Partner at Osborne Clarke, to explore these developments and what they could mean for healthcare and life sciences transactions in 2026.

Sustainable weight loss “needs behavioural change” — Lisa Tookey, CheqUp

GLP-1 weight loss drugs are now widely used in the UK, with around 2.5 million people taking them. The market has grown fast, raising questions about how safely these medications are prescribed and how much support patients receive. NHS access is still limited and varies depending on where you live. As a result, many people are choosing to go private. 

Interview: Jason Powell, CEO of UK Vein Clinic

HBI talks to Jason Powell, CEO of UK Vein Clinic, a low-cost outpatient chain for vericose vein treatment on the company's national expansion and the UK vein care market. UK Vein Clinic has announced plans to expand its network, with the launch of 17 new clinics in 2026.

Interview: Andy Scaife, SSP Health

SSP Health is one of only a handful of corporately-run primary care chains in the UK. It was founded in 2002 by two GP partners, Dr. Shikha Pitalia and Dr. Sanjay Pitalia, who are married. It has since grown to 45 practices, most of which are located in the North West of England.

Interview: George Tomeski, Helfie AI

Helfie AI is an Australian start-up that is building what its founder, George Tomeski, describes as “a whole new operating system for human health”. This is not simply hyperbole or PR-speak. What Helfie is building is indeed groundbreaking.

2025 saw considered uptick in European healthcare deals, momentum set to continue into 2026 — Elizabeth Todd, Ropes & Gray

2025 has been a year of gradual recovery for healthcare investments in Europe, according to Elizabeth Todd, Partner and Co-Lead, European Private Equity Transactions Practice at the global law firm Ropes & Gray.

Medtech and minimally invasive devices to see strong growth in 2026 — Amit Karna, Keensight Capital

2025 has been a strong year overall for healthcare investments. In this interview, HBI speaks to Amit Karna, Partner at Keensight Capital, a European growth buyout investor.

Interview: Neil Daly, Skin Analytics

Skin Analytics is a UK company that has developed an AI-based software tool to analyse whether patients with skin lesions have cancer. In a conversation with HBI, the company’s CEO, Neil Daly, explained how AI tools need to be able to make accurate clinical decisions autonomously, without human input, in order to provide an efficiency benefit to the healthcare system.

Find Us